Journal profile · Neuroscience-Cellular and Molecular Neuroscience
Experimental Neurobiology
ISSN 1226-2560 · eISSN 2093-8144 · Korean Society for Brain and Neural Science · South Korea
Experimental Neurobiology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.38; fully open access; median 68 days to acceptance (53 articles, last 24 months); 26 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Experimental Neurobiology is published by Korean Society for Brain and Neural Science and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroscience and Neuropharmacology Research, Neuroinflammation and Neurodegeneration Mechanisms and Parkinson's Disease Mechanisms and Treatments, together about 29.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Experimental Neurobiology is an international forum for interdisciplinary investigations of the nervous system. The journal aims to publish papers that present novel observations in all fields of neuroscience, encompassing cellular & molecular neuroscience, development/differentiation/plasticity, neurobiology of disease, systems/cognitive/behavioral neuroscience, drug development & industrial application, brain-machine interface, methodologies/tools, and clinical neuroscience. It should be of interest to a broad scientific audience working on the biochemical, molecular biological, cell biological, pharmacological, physiological, psychophysical, clinical, anatomical, cognitive, and biotechnological aspects of neuroscience. The journal publishes both original research articles and review articles. Experimental Neurobiology is an open access, peer-reviewed online journal. The journal is published jointly by The Korean Society for Brain and Neural Sciences & The Korean Society for Neurodegenerative Disease.
Source: LetPub
Research area (LetPub): Neuroscience-Cellular and Molecular Neuroscience
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroscience and Neuropharmacology ResearchNeuroscience13.2%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience10.2%
- Parkinson's Disease Mechanisms and TreatmentsMedicine6.6%
- Neurogenesis and neuroplasticity mechanismsNeuroscience6.6%
- Alzheimer's disease research and treatmentsMedicine5.7%
- Stress Responses and CortisolNeuroscience5.3%
- Nerve injury and regenerationNeuroscience4.9%
- Memory and Neural MechanismsNeuroscience3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.38LetPub ·
- CiteScore 2026-06
- 3.9LetPub ·
- SJR 2026-06
- 0.94LetPub ·
- SNIP 2026-06
- 0.64LetPub ·
- h-index
- 8LetPub ·
- h-index
- 61OpenAlex ·
- i10-index
- 365OpenAlex ·
- 2-year mean citedness
- 1.93OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 24LetPub ·
Articles by year OpenAlex count · 633 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 20 | 9 |
| 2025 | 26 | 26 | 58 |
| 2024 | 25 | 25 | 70 |
| 2023 | 35 | 35 | 329 |
| 2022 | 35 | 35 | 347 |
| 2021 | 37 | 37 | 467 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
68 daysMedian, submission to acceptance · P25–P75 33 days – 99 days
- Acceptance to online
- median 21 days (52 articles)
- Submission to online
- median 93 days
- Sample
- 53 articles with submission and acceptance dates (54 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Korean Society for Brain and Neural Science
- Country or region
- South Korea
- Language
- English
- ISSN
- 1226-2560
- Electronic ISSN
- 2093-8144
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Experimental Neurobiology
What CAS zone is Experimental Neurobiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Experimental Neurobiology is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental / Neurosciences. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Experimental Neurobiology?
The latest impact factor listed by LetPub is 2.38; CiteScore 3.9, h-index 61.
How long does peer review take at Experimental Neurobiology?
Based on the dates recorded on 53 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 33–99 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Experimental Neurobiology?
According to LetPub and DOAJ records, Experimental Neurobiology is indexed in SCIE and Scopus.
Is Experimental Neurobiology open access, and what is the APC?
Experimental Neurobiology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .